Joshua R. Disbrow
Net Worth

Last updated:

What is Joshua R. Disbrow net worth?

The estimated net worth of Mr. Joshua R. Disbrow is at least $9,244,637 as of 14 Jun 2023. He owns shares worth $154,637 as insider and has received compensation worth at least $9,090,000 in Aytu BioPharma, Inc..

What is the salary of Joshua R. Disbrow?

Mr. Joshua R. Disbrow salary is $1,010,000 per year as Chairman & Chief Executive Officer in Aytu BioPharma, Inc..

How old is Joshua R. Disbrow?

Mr. Joshua R. Disbrow is 50 years old, born in 1975.

What stocks does Joshua R. Disbrow currently own?

As insider, Mr. Joshua R. Disbrow owns shares in one company:

Company Title Shares Price per share Total value
Aytu BioPharma, Inc. (AYTU) Chairman & Chief Executive Officer 71,591 $2.16 $154,637

What does Aytu BioPharma, Inc. do?

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

AYTU logo
AYTU
Aytu BioPharma, Inc.
$2.16

Joshua R. Disbrow insider trading

Aytu BioPharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Shares 14,000 $1.86 $26,082
Purchase
Common Stock 112,371 $0.22 $25,059
Purchase
Common Shares 222,000 $0.24 $52,614
Purchase
Common Stock 55,000 N/A N/A
Purchase
Warrants (right to buy) 5,000 N/A N/A
Purchase
Warrants 226,105 $0.54 $122,097
Purchase
Common Stock 226,105 $0.54 $122,097
Option
Warrant to Purchase Common Stock 166,666 $1.86 $309,999
Option
Common Stock 187,500 $0.75 $140,625
Purchase
Warrant to Purchase Common Stock 28,924 $6 $173,544
Purchase
Common Stock 166,666 $1.86 $309,999
Purchase
Warrant to Purchase Common Stock 166,666 $1.86 $309,999
Purchase
Common Stock 250,000 $0.4 $100,000
Purchase
Warrant to Purchase Common Stock 250,000 $0.5 $125,000
Purchase
Common Stock 153,846 $0.65 $100,000

Aytu BioPharma key executives

Aytu BioPharma, Inc. executives and other stock owners filed with the SEC: